Trends in incidence and mortality of prostate cancer in Huangpu District from 2002 to 2019
ZHAO Junfeng, HE Lihua, LI Weiyi, ZOU Yawei, CHEN Bo, NIU Xin, GAO Shuna
Department of Chronic Disease Control and Prevention, Huangpu District Center for Disease Control and Prevention(Huangpu District Health Supervision Institute), Shanghai 200023, China
Abstract：Objective To investigate the trends in incidence and mortality of prostate cancer in Huangpu District, Shanghai Municipality from 2002 to 2019, so as to provide insights into the prevention and treatment of prostate cancer. Methods The incidence and mortality of prostate cancer among men in Huangpu District from 2002 to 2019 were collected from the Shanghai Cancer Registry System. The crude incidence, crude mortality, truncated age-standardized incidence (aged 35 to 64 years) and cumulative incidence (aged 0 to 74 years) of prostate cancer were calculated. The Chinese Fifth National Population Census in 2000 and the Segi's world standard population in 1960 were used to calculate Chinese-standardized rate and world-standardized rate. The trends in incidence and mortality of prostate cancer were evaluated using annual percent change (APC) and average annual percent change (AAPC). Results A total of 2 672 cases of prostate cancer were reported in Huangpu District from 2002 to 2019, and the crude incidence was 33.35/105, the Chinese-standardized incidence was 14.93/105 and the world-standardized incidence was 12.37/105 (AAPC=7.675%, 4.886% and 4.983%, all P<0.05). The incidence of prostate cancer among males at ages of 60 to <70 years and 70 to <80 years appeared increasing trends (AAPC=4.554% and 5.045%, both P<0.05). A total of 1 214 deaths of prostate cancer were reported, and the crude mortality was 15.15/105, the Chinese-standardized mortality was 6.01/105 and the world-standardized mortality was 4.61/105 (AAPC=5.500%, 2.057% and 1.784%, all P<0.05). The mortality of prostate cancer among males at ages of 80 years and above appeared an increasing trend (AAPC=4.220%, P<0.05). Conclusions The incidence and mortality of prostate cancer appeared increasing trends in Huangpu District from 2002 to 2019, and the incidence among males at ages of 60 years and above also increased. The screening for prostate cancer among males at ages of 60 years and above should be strengthened.
赵俊峰, 何丽华, 李为翊, 邹亚伟, 陈博, 牛欣, 高淑娜. 2002—2019年黄浦区前列腺癌发病和死亡趋势[J]. 预防医学, 2024, 36(10): 878-881,886.
ZHAO Junfeng, HE Lihua, LI Weiyi, ZOU Yawei, CHEN Bo, NIU Xin, GAO Shuna. Trends in incidence and mortality of prostate cancer in Huangpu District from 2002 to 2019. Preventive Medicine, 2024, 36(10): 878-881,886.
[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249. [2] 国家卫生健康委办公厅.前列腺癌诊疗指南(2022年版)[EB/OL].[2024-07-31].http://www.nhc.gov.cn/yzygj/s7659/202204/a0e67177df1f439898683e1333957c74/files/64eb7728ee494e299a 77846fff09840e.pdf. [3] 刘灿,李想,王雷,等.2005—2014年中国前列腺癌流行特征[J].中华疾病控制杂志,2021,25(7):806-811. [4] PERNAR C H,EBOT E M,WILSON A,et al.The epidemiology of prostate cancer[J/OL].Cold Spring Harb Perspect Med,2018,8(12)[2024-07-31].https://doi.org/10.1101/cshperspect.a030361. [5] 鲁欣,蒋栋铭,胡明,等.2004—2018年全国前列腺癌死亡率的流行特征及时间趋势[J].上海预防医学,2021,33(10):899-904,312. [6] 龚杨明,彭鹏,吴春晓,等.2016年上海市前列腺癌发病和死亡情况与2002—2016年变化趋势分析[J].肿瘤,2023,43(4):297-306. [7] 顾凯,庞怡,吴春晓,等.2017年上海市恶性肿瘤发病和死亡情况与2002—2017年的变化趋势分析[J].肿瘤,2023,43(4):241-256. [8] 郑荣寿,陈茹,韩冰峰,等.2022年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2024,46(3):221-231. [9] 上海市黄浦区统计局. 2022年黄浦统计年鉴[EB/OL].[2024-07-31].https://www.shhuangpu.gov.cn/zw/009002/009002032/009002032004/009002032004005/20230316/647b5d 95-1bc4-4df9-9a73-a25ecba90ab1.html. [10] 秦敏晔,邱晶,王洵之,等.2006—2022年张家港市60岁及以上居民前列腺癌疾病负担分析[J].预防医学,2023,35(12):1080-1083,1088. [11] 王军,陈永胜,张永辉,等.1972—2016年江苏省启东市前列腺癌发病率与死亡率趋势分析[J].中国肿瘤,2021,30(10):746-753. [12] 洪思捷,宋芯蕊,陈丹琪,等.2013—2017年广东省男性前列腺癌流行特征及趋势[J].现代预防医学,2023,50(8):1356-1360. [13] 赵俊峰,陈希,俞捷,等.2014—2019年上海市黄浦区居民慢性病健康相关行为的变化趋势[J]. 上海预防医学,2023,35(7):689-694. [14] WANG L,LU B,HE M J,et al.Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019[J/OL].Front public health,2022,10[2024-07-31].https://doi.org/10.3389/fpubh.2022.811044. [15] 赫捷,陈万青,李霓,等.中国前列腺癌筛查与早诊早治指南(2022,北京)[J].中华肿瘤杂志,2022,44(1):29-53. [16] SIEGEL R L,GIAQUINTO A N,JEMAL A.Cancer statistics,2024[J].CA Cancer J Clin,2024,74(1):12-49.
